RemoniHealth, a leading medical technology firm specializing in vision monitoring and extended care solutions, has announced a major achievement: surpassing 80,000 remote monitoring encounters for patients with chronic retinal diseases. This milestone highlights the company’s ongoing commitment to transforming remote care management and diagnostics, particularly for conditions like age-related macular degeneration (AMD) and diabetic retinopathy.
The achievement comes as the company experiences a surge in patient enrollment in its early access program, which has seen significant growth over the past year. This increase underscores the growing adoption of RemoniHealth’s solutions among eye care providers and their patients, emphasizing the crucial role of remote diagnostic monitoring in enhancing patient care.
Next-Gen Digital Platform and New Pilot Program
Building on this success, RemoniHealth is set to roll out its next-generation 2.0 integrated digital service platform, which offers expanded care management capabilities. Additionally, the company is piloting a comprehensive remote monitoring and care management service for glaucoma, known as Glaucoma 360. This service includes at-home intraocular pressure (IOP) testing and online perimetry, providing eye care practices with tools to enhance patient engagement, streamline disease monitoring, and improve compliance with Medicare and commercial health insurance reimbursement standards.
Success of Macustat Retina Product Line
The company’s Macustat retina product line has been pivotal in driving this success. The early access program, now implemented at top retina practices such as Retina Consultants of America (RCA) and OCLI/Spectrum Vision Partners, has facilitated out-of-clinic remote monitoring for patients managing chronic eye diseases. These encounters are central to the creation of the largest validated enterprise system for multi-specialty remote physiologic monitoring in eye care.
Dr. Robert Avery, Founder and CEO of California Retina Consultants and a member of RCA, commented on the expansion: “We are excited to offer remote care services to our retina patients. It extends our care beyond the busy clinic lanes, and patients appreciate the high-touch engagement, knowing their condition is being continuously monitored between visits.”
Expansion Plans Beyond Eye Care
With this momentum, RemoniHealth plans to expand its focus to chronic conditions beyond retinal diseases, starting with glaucoma. This expansion is part of the company’s broader mission to address a variety of chronic diseases through innovative remote monitoring and management solutions. RemoniHealth also has plans to extend its services into other healthcare areas, furthering its goal of improving patient outcomes across multiple disease categories.
About RemoniHealth
RemoniHealth is a private medical technology company dedicated to revolutionizing eye care practices with its cutting-edge remote monitoring and care management solutions. By leveraging advanced technology, the company enhances patient engagement, compliance, and monitoring for chronic eye diseases, setting a new standard in remote healthcare management.
Related topic:
Eye Care Associates Adopts Nextech’s Ophthalmic Platform
Malang Tank Launches Eye Care Solutions, Aims for Global Growth
Homelist Unveils the LH1 Forest Light Full Spectrum Eye-Care Floor Lamp
